http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2510406-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 1982-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2110f2788b43579fc4a7add399e1a3a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17f9159f74d388a7041db31dd7d5c5e
publicationDate 1983-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2510406-A1
titleOfInvention PHARMACEUTICAL COMPOSITION CONTAINING IN COMBINATION OF 6,7-DICHLORO-1,5-DIHYDROIMIDAZO (2,1-B) QUINAZOLIN-2 (3H) -ONE AND AN ANTI-INFLAMMATORY AGENT
abstract THE INVENTION RELATES TO THE FIELD OF PHARMACEUTICAL CHEMISTRY. IT CONCERNS A NEW PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION OF ANAGRELIDE, THAT IS TO SAY 6,7-DICHLORO-1,5-DIHYDROIMIDAZO 2,1-B QUINAZOLINE-2 (3H) -ONE AND A QUANTITY , CAPABLE OF ENHANCING THE ACTIVITY OF THIS SUBSTANCE, OF A NON-STEROIDIC ANTI-INFLAMMATORY AGENT CHOSEN FROM THE GROUP CONSISTING OF ACETYLSALICYLIC ACID, ZOMEPIRAC, IBUPROFENE, NAPROXENE, SULFINPETHYRAZINE AND PHOINDUOMINE . THE OVERADDITIVE EFFECTS OF THE NEW ASSOCIATIONS ACCORDING TO THE INVENTION ALLOWS THE COMPOSITIONS CONTAINING THEM TO BE USED IN THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF THROMBOSIS AND OTHER DISORDERS ASSOCIATED WITH AGGREGATION OF BLOOD PLATES.
priorityDate 1981-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360260
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421789662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565652
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID352190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457231771
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452890348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4220146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7059571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16220118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452615227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426023561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344381

Total number of triples: 71.